Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
暂无分享,去创建一个
Jeong-Sook Park | Min-Soo Kim | Sung-Joo Hwang | Jeong-Sook Park | Sung-Joo Hwang | Dong-Han Won | Sibeum Lee | Sibeum Lee | D. Won | Min‐Soo Kim | S. Hwang
[1] C. Washington,et al. Chemical stability of total parenteral nutrition mixtures , 1992 .
[2] K M Park,et al. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. , 1999, International journal of pharmaceutics.
[3] Koji Takahashi,et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[4] A. Ellrodt,et al. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. , 1988, Drugs.
[5] S. Riegelman,et al. Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.
[6] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[7] Molar solubility of felodipine in different aqueous systems , 1992 .
[8] Dennis E. Koppel,et al. Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .
[9] K. Johnston,et al. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. , 2002, International journal of pharmaceutics.
[10] D. McTavish,et al. Verapamil , 2012, Drugs.
[11] B. Edgar,et al. Felodipine Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.
[12] Ž. Knez,et al. Improvement of nifedipine dissolution characteristics using supercritical CO2 , 1997 .
[13] Jeong-Sook Park,et al. Solubility enhancers for oral drug delivery , 2004 .
[14] Sun‐Ho Kang,et al. Preparation and Characterization of Lysozyme Nanoparticles using Solution Enhanced Dispersion by Supercritical Fluid (SEDS) Process , 2005 .
[15] Eric Doelker,et al. Influence of the preparation method on residual solvents in biodegradable microspheres , 1996 .
[16] Ž. Knez,et al. Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.
[17] A. Juppo,et al. Evaluation of controlled-release polar lipid microparticles. , 2002, International journal of pharmaceutics.
[18] Chong-K. Kim,et al. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. , 2002, International journal of pharmaceutics.
[19] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] G. Tytgat,et al. Gastric Transit and Pharmacodynamics of a Two-Millimeter Enteric-Coated Pancreatin Microsphere Preparation in Patients with Chronic Pancreatitis , 2004, Digestive Diseases and Sciences.
[21] P. Kleinebudde,et al. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. , 1997, Journal of pharmaceutical sciences.
[22] Emilio Squillante,et al. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. , 2002, Journal of pharmaceutical sciences.
[23] P. Augustijns,et al. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. , 2003, International journal of pharmaceutics.